Luqa signs commercialization deal with BMG Pharma in China, Hong Kong
The products included in the agreement are IaluXid, a non-antibiotic, combination gel formulation treating skin infections; oral Mucositis and Xerostomia therapies GelX and GelX Xero; and Aftacure, treating
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.